Yuichiro Tada

2.6k total citations
88 papers, 1.3k citations indexed

About

Yuichiro Tada is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Yuichiro Tada has authored 88 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 55 papers in Oncology and 25 papers in Otorhinolaryngology. Recurrent topics in Yuichiro Tada's work include Salivary Gland Tumors Diagnosis and Treatment (47 papers), Ear and Head Tumors (38 papers) and Head and Neck Cancer Studies (23 papers). Yuichiro Tada is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (47 papers), Ear and Head Tumors (38 papers) and Head and Neck Cancer Studies (23 papers). Yuichiro Tada collaborates with scholars based in Japan, United States and Netherlands. Yuichiro Tada's co-authors include Toshitaka Nagao, Tatsuo Masubuchi, Daisuke Kawakita, Hideaki Takahashi, Chihiro Fushimi, Kouki Miura, Takashi Matsuki, Hideaki Hirai, Masato Nakaguro and Hiroya Ojiri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yuichiro Tada

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichiro Tada Japan 21 892 791 275 252 228 88 1.3k
Mohemmed N. Khan United States 20 744 0.8× 367 0.5× 99 0.4× 421 1.7× 198 0.9× 51 984
Norihiko Okada Japan 24 626 0.7× 466 0.6× 220 0.8× 472 1.9× 387 1.7× 106 1.5k
Jacob Kligerman Brazil 16 1.1k 1.2× 828 1.0× 96 0.3× 776 3.1× 246 1.1× 37 1.5k
Paolo Potepan Italy 15 483 0.5× 421 0.5× 84 0.3× 325 1.3× 73 0.3× 39 874
Jatin P. Shah United States 13 872 1.0× 676 0.9× 71 0.3× 717 2.8× 101 0.4× 14 1.2k
Masao Asai Japan 16 742 0.8× 358 0.5× 50 0.2× 422 1.7× 105 0.5× 53 1.1k
Joon Kyoo Lee South Korea 16 475 0.5× 256 0.3× 129 0.5× 231 0.9× 99 0.4× 128 951
Márcia Cristina da Costa Miguel Brazil 20 288 0.3× 265 0.3× 221 0.8× 161 0.6× 442 1.9× 102 1.2k
Luca Calabrese Italy 23 888 1.0× 501 0.6× 83 0.3× 816 3.2× 93 0.4× 83 1.5k
Vanni Mondin Italy 14 820 0.9× 606 0.8× 78 0.3× 510 2.0× 143 0.6× 20 1.2k

Countries citing papers authored by Yuichiro Tada

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Tada more than expected).

Fields of papers citing papers by Yuichiro Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Tada. The network helps show where Yuichiro Tada may publish in the future.

Co-authorship network of co-authors of Yuichiro Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Tada. A scholar is included among the top collaborators of Yuichiro Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Tada. Yuichiro Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kano, Satoshi, Ichiro Kinoshita, Yuichiro Tada, et al.. (2025). Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer. Japanese Journal of Clinical Oncology. 55(10). 1131–1140. 1 indexed citations
3.
4.
Okada, Takuro, Chihiro Fushimi, Takashi Matsuki, et al.. (2023). Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study. Anticancer Research. 43(6). 2717–2724. 5 indexed citations
5.
Matsuki, Takashi, Chihiro Fushimi, Hiroki Sato, et al.. (2022). Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Anticancer Research. 42(10). 4907–4912. 3 indexed citations
6.
Murase, Takayuki, Toshitaka Nagao, Kimihide Kusafuka, et al.. (2021). Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological features. Histopathology. 80(4). 729–735. 14 indexed citations
7.
Morita, Maki, Takayuki Murase, Yuma Sakamoto, et al.. (2020). Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma. Histopathology. 76(7). 1013–1022. 12 indexed citations
8.
Murase, Takayuki, Daisuke Kawakita, Toshitaka Nagao, et al.. (2020). Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study. Cancer Science. 111(11). 4195–4204. 21 indexed citations
9.
Uijen, Maike J.M., Adriana C. H. van Engen–van Grunsven, Yuichiro Tada, et al.. (2020). Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. Cancer Treatment Reviews. 89. 102069–102069. 35 indexed citations
10.
Fushimi, Chihiro, et al.. (2020). Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. In Vivo. 34(5). 2653–2657. 8 indexed citations
11.
Matsuki, Takashi, Isaku Okamoto, Yuichiro Tada, et al.. (2020). Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach. Annals of Surgical Oncology. 28(6). 3066–3072. 7 indexed citations
12.
Fushimi, Chihiro, Isaku Okamoto, Takashi Matsuki, et al.. (2020). Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma. Anticancer Research. 40(9). 5277–5283. 23 indexed citations
13.
Murase, Takayuki, Hisashi Takino, Ayako Masaki, et al.. (2018). Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3‐MAML2 fusions. Head & Neck. 40(12). 2565–2573. 8 indexed citations
14.
Tada, Yuichiro, et al.. (2016). A case of very elderly patient with multiple cervical metastases of salivary duct carcinoma successfully treated by anti-androgen and proton beam therapies. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 29(1). 56–60. 1 indexed citations
15.
Otsuka, Kuninori, Yorihisa Imanishi, Yuichiro Tada, et al.. (2016). Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients. Annals of Surgical Oncology. 23(6). 2038–2045. 67 indexed citations
16.
Kamata, Masahiro, et al.. (2011). Drug fever caused by eutectic mixture of local anesthetic cream.. PubMed. 21(5). 421–421. 1 indexed citations
17.
Yoshimoto, Seiichi, Shin‐etsu Kamata, Kazuyoshi Kawabata, et al.. (2005). MODIFIED RADICAL NECK DISSECTION FOR POSITIVE LYMPH NODE CASES WITH TONGUE CANCER OR HYPOPHARYNGEAL CANCER. Toukeibu Gan. 31(3). 376–381. 2 indexed citations
18.
Beppu, Takeshi, Hiroki Mitani, Kazuyoshi Kawabata, et al.. (2005). PRIMARY CONTROL OF UPPER GINGIVA AND HARD PALATE SQUAMOUS CELL CARCINOMA: A CLINICAL EVALUATION. Toukeibu Gan. 31(1). 22–27. 1 indexed citations
19.
Tada, Yuichiro, et al.. (2000). Endoscopic Transnasal Transsphenoidal Surgery for Pituitary Tumors -Intranasal Procedures.. Nippon Jibiinkoka Gakkai Kaiho. 103(3). 212–218. 1 indexed citations
20.
Iijima, Toru, Yuichiro Tada, Yuji Hidaka, et al.. (1998). Prediction of postpartum onset of rheumatoid arthritis. Annals of the Rheumatic Diseases. 57(8). 460–463. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohemmed N. Khan Breakdown of academic impact, for papers by Norihiko Okada Breakdown of academic impact, for papers by Jacob Kligerman Breakdown of academic impact, for papers by Paolo Potepan Breakdown of academic impact, for papers by Jatin P. Shah Breakdown of academic impact, for papers by Masao Asai Breakdown of academic impact, for papers by Joon Kyoo Lee Breakdown of academic impact, for papers by Márcia Cristina da Costa Miguel Breakdown of academic impact, for papers by Luca Calabrese Breakdown of academic impact, for papers by Vanni Mondin
Rankless by CCL
2026